A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects
Clinical trial NCT01696604 · COMPLETED
Trial details
- NCT number
- NCT01696604
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-26
- Primary completion
- 2013-05-03
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.